NUCLEOLIN and hepatocellular carcinoma: Finally, to verify the universality of the circ0006646/NCL/p53/E cadherin axis, we further chose HCC patients (cohort 1) with distinct circ0006646 expression levels to evaluate the relevance of this axis.